|
|
|
|
Vol. 60, Issue 2, 262-266, August 2001
Division of Clinical Virology, Karolinska Institute, Huddinge
University Hospital, Stockholm, Sweden
The multisubstrate deoxyribonucleoside kinase of
Drosophila melanogaster (Dm-dNK) can be
expressed in human cells with retained enzymatic activity. The cells
expressing Dm-dNK exhibit increased sensitivity to
several cytotoxic nucleoside analogs. In this study, we further
evaluated Dm-dNK as a potential novel suicide gene in
combination with (E)-5-(2-bromovinyl)-2'-deoxyuridine
(BVDU) as the prodrug. We used two human cancer cell lines transduced with a retrovirus encoding the Dm-dNK cDNA and
investigated whether the cells expressing the enzyme can induce cell
death of untransduced cells, a phenomenon known as the "bystander
effect". A bystander effect was observed in a thymidine
kinase-deficient human osteosarcoma cell line but not in the MIA PaCa-2
human pancreatic adenocarcinoma cell line. The cytotoxicity of BVDU
increased in both cell lines when the compound was used in combination
with subtoxic concentrations of hydroxyurea. Hydroxyurea also enhanced
the bystander effect in the osteosarcoma cells, but not in the MIA
PaCa-2 cells, treated with BVDU. These findings indicate that BVDU
phosphorylated by Dm-dNK in transduced cancer cells may
also induce bystander cell death in certain cell lines.
This article has been cited by other articles:
![]() |
N. Solaroli, X. Zheng, M. Johansson, J. Balzarini, and A. Karlsson Mitochondrial Expression of the Drosophila melanogaster Multisubstrate Deoxyribonucleoside Kinase Mol. Pharmacol., December 1, 2007; 72(6): 1593 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zheng, M. Lundberg, A. Karlsson, and M. Johansson Lipid-mediated Protein Delivery of Suicide Nucleoside Kinases Cancer Res., October 15, 2003; 63(20): 6909 - 6913. [Abstract] [Full Text] [PDF] |
||||